Chimeric antigen receptor T-Cell immunotherapy for hepatobiliary and pancreatic tumors: a Meta-analysis

• Changqi Du,
• Linlin Wang,
• Ruozhu Dong,
• Hongling Li

Affiliations

Changqi Du

The First School of Clinical Medical, Gansu University of Chinese Medicine, Lanzhou City, 730000, Gansu Province, China; Department of Oncology, Gansu Provincial Hospital, Lanzhou City, 730000, Gansu Province, China

Linlin Wang

The First School of Clinical Medical, Gansu University of Chinese Medicine, Lanzhou City, 730000, Gansu Province, China; Department of Oncology, Gansu Provincial Hospital, Lanzhou City, 730000, Gansu Province, China

Ruozhu Dong

The First School of Clinical Medical, Gansu University of Chinese Medicine, Lanzhou City, 730000, Gansu Province, China

Hongling Li

Corresponding author: Gansu Provincial People's Hospital; The First School of Clinical Medical, Gansu University of Chinese Medicine, Lanzhou City, 730000, Gansu Province, China; Department of Oncology, Gansu Provincial Hospital, Lanzhou City, 730000, Gansu Province, China